Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
November 17, 2021
Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa
Fang-Yuan Zhang, Run-Ze Li, Cong Xu, et al.
Stem Cell Reviews and Reports
|
January 24, 2020
Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy
Lulu E Yan, Hongyu Zhang, Masayuki Wada, et al.
Pharmacological Research
|
May 8, 2021
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8<sup>+</sup> T cells
Ze-Bo Jiang, Cong Xu, Wenjun Wang, et al.
Pharmacological Research
|
April 3, 2022
Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response
Xuan-Run Wang, Ze-Bo Jiang, Cong Xu, et al.
Cell Death & Disease
|
October 30, 2019
MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer
Fu-Gang Duan, Mei-Fang Wang, Ya-Bing Cao, et al.
Journal of Cancer Research and Clinical Oncology
|
April 6, 2020
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer
Hui You, Yi-Zhong Zhang, Huan-Ling Lai, et al.
Cancer Letters
|
May 30, 2021
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
Ze-Bo Jiang, Wen-Jun Wang, Cong Xu, et al.
World Journal of Gastrointestinal Oncology
|
May 18, 2022
Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway
Yong-Jie Teng, Zhe Deng, Zhao-Guang Ouyang, et al.
International Journal of Cancer
|
February 21, 2019
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer
Elaine Lai-Han Leung, Lian Xiang Luo, Ying Li, et al.
Nature Communications
|
August 22, 2023
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy
Elaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
November 17, 2021
Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa
Fang-Yuan Zhang, Run-Ze Li, Cong Xu, et al.
Stem Cell Reviews and Reports
|
January 24, 2020
Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy
Lulu E Yan, Hongyu Zhang, Masayuki Wada, et al.
Pharmacological Research
|
May 8, 2021
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8<sup>+</sup> T cells
Ze-Bo Jiang, Cong Xu, Wenjun Wang, et al.
Pharmacological Research
|
April 3, 2022
Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response
Xuan-Run Wang, Ze-Bo Jiang, Cong Xu, et al.
Cell Death & Disease
|
October 30, 2019
MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer
Fu-Gang Duan, Mei-Fang Wang, Ya-Bing Cao, et al.
Journal of Cancer Research and Clinical Oncology
|
April 6, 2020
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer
Hui You, Yi-Zhong Zhang, Huan-Ling Lai, et al.
Cancer Letters
|
May 30, 2021
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
Ze-Bo Jiang, Wen-Jun Wang, Cong Xu, et al.
World Journal of Gastrointestinal Oncology
|
May 18, 2022
Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway
Yong-Jie Teng, Zhe Deng, Zhao-Guang Ouyang, et al.
International Journal of Cancer
|
February 21, 2019
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer
Elaine Lai-Han Leung, Lian Xiang Luo, Ying Li, et al.
Nature Communications
|
August 22, 2023
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy
Elaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan, et al.
Page
of 8